Aurora Completes First-Ever EU-GMP Certification for Its Dedicated Distribution Centre

*EDMONTON, AB* – Aurora Cannabis Inc.’s dedicated distribution centre
located in Brampton, Ontario, has received European Union Good
Manufacturing Practice (“EU-GMP”) certification, increasing the company’s
international export capabilities. The distribution centre joins Aurora’s
group of manufacturing facilities in Canada and Europe certified against EU
standards.

“Securing EU-GMP certification at manufacturing and distribution facilities
within our network is an important validation of our differentiated
approach to operating as a global medical cannabis company,” said Jill Lau,
Vice President of Canadian Operations at Aurora. “By adding certification
for our distribution centre, we are now uniquely positioned to ensure
patients worldwide have consistent access to superior quality medical
cannabis from the largest Canadian exporter.”

EU-GMP certification is granted to companies whose production facilities
meet the requirements under the EudraLex “Rules Governing Medicinal
Products in the European Union,” and that can demonstrate a high degree of
quality and consistency in their manufacturing procedures, a requirement
for the export of medical cannabis products into Europe. EU-GMP
certification of the company’s distribution centre allows it to serve as a
centralized site for more optimized and efficient receipt, storage and
distribution of materials and finished products internationally.

With operations across Canada and in Europe, Aurora remains at the
forefront of the global medical cannabis industry. By continuously
investing in operational capabilities, regulatory excellence, and a
science-led approach, Aurora is positioned to deliver medical cannabis that
meets and exceeds the highest international standards.
About Aurora Cannabis Inc.

Aurora serves both the medical and consumer markets across Canada, Europe,
Australia and New Zealand. The Company’s adult-use brand portfolio includes
Drift, San Rafael ’71, Daily Special, Tasty’s, Being and Greybeard. Medical
cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical
Marijuana Co., as well as international brands, Pedanios, IndiMed and
CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., a
leading supplier of propagated agricultural plants. Aurora’s common shares
trade on the NASDAQ and TSX under the symbol ACB.